Advertisement.

HQL Projected Dividend Yield

Sh Ben Int/abrdn Life Sciences Investors ( NYSE : HQL )

Tekla Life Sciences Investors is a non-diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in United States and foreign companies in the life sciences industry (including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies), agriculture and environmental management. The Fund invests primarily in securities of public and private companies.

10 YEAR PERFORMANCE RESULTS

HQL Dividend History Detail
HQL Dividend News
HQL Competitors News

# of Shares: 0

Closing Price: 12.97

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2024	1.38	0%	0	$ 0.00	10.64%
2025	0.69	0%	0	$ 0.00	10.64%
2026	0.69	0%	0	$ 0.00	10.64%
2027	0.69	0%	0	$ 0.00	10.64%
2028	0.69	0%	0	$ 0.00	10.64%
2029	0.69	0%	0	$ 0.00	10.64%
2030	0.69	0%	0	$ 0.00	10.64%
2031	0.69	0%	0	$ 0.00	10.64%
2032	0.69	0%	0	$ 0.00	10.64%
2033	0.69	0%	0	$ 0.00	10.64%
2034	0.69	0%	0	$ 0.00	10.64%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10yrs would be $ 0.00 with a yield on cost % of 10.64%
Rolling Last 4 qtrs dividends total $ 0.69 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.69 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
2024	Feb 09, 2024	Feb 21, 2024	Feb 22, 2024	Mar 28, 2024	0.3900
2024	Nov 09, 2023	Nov 21, 2023	Nov 22, 2023	Jan 10, 2024	0.3000
2024 Total:					0.6900